Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Welireg (belzutifan)
i
Other names:
MK-6482, PT 2977, PT-2977, PT2977, MK6482, MK 6482
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(9)
News
Trials
Company:
Merck (MSD)
Drug class:
HIF-2α inhibitor
Related drugs:
‹
BPI-452080 (0)
DFF332 (0)
K-1299 (0)
NKT2152 (0)
SLM (0)
BPI-452080 (0)
DFF332 (0)
K-1299 (0)
NKT2152 (0)
SLM (0)
›
Associations
(9)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Renal Cell Carcinoma
No biomarker
Renal Cell Carcinoma
belzutifan
Sensitive: A1 - Approval
belzutifan
Sensitive
:
A1
belzutifan
Sensitive: A1 - Approval
belzutifan
Sensitive
:
A1
VHL mutation
Neuroendocrine Tumor
VHL mutation
Neuroendocrine Tumor
belzutifan
Sensitive: A1 - Approval
belzutifan
Sensitive
:
A1
belzutifan
Sensitive: A1 - Approval
belzutifan
Sensitive
:
A1
VHL mutation
CNS Tumor
VHL mutation
CNS Tumor
belzutifan
Sensitive: A1 - Approval
belzutifan
Sensitive
:
A1
belzutifan
Sensitive: A1 - Approval
belzutifan
Sensitive
:
A1
VHL mutation
Renal Cell Carcinoma
VHL mutation
Renal Cell Carcinoma
belzutifan
Sensitive: A1 - Approval
belzutifan
Sensitive
:
A1
belzutifan
Sensitive: A1 - Approval
belzutifan
Sensitive
:
A1
No biomarker
Kidney Cancer
No biomarker
Kidney Cancer
belzutifan
Sensitive: A2 - Guideline
belzutifan
Sensitive
:
A2
belzutifan
Sensitive: A2 - Guideline
belzutifan
Sensitive
:
A2
VHL mutation
Clear Cell Renal Cell Carcinoma
VHL mutation
Clear Cell Renal Cell Carcinoma
belzutifan
Sensitive: C1 - Off-label
belzutifan
Sensitive
:
C1
belzutifan
Sensitive: C1 - Off-label
belzutifan
Sensitive
:
C1
VHL mutation
Glioblastoma
VHL mutation
Glioblastoma
belzutifan
Sensitive: C1 - Off-label
belzutifan
Sensitive
:
C1
belzutifan
Sensitive: C1 - Off-label
belzutifan
Sensitive
:
C1
EPAS1 G323E
Clear Cell Renal Cell Carcinoma
EPAS1 G323E
Clear Cell Renal Cell Carcinoma
belzutifan
Sensitive: D – Preclinical
belzutifan
Sensitive
:
D
belzutifan
Sensitive: D – Preclinical
belzutifan
Sensitive
:
D
EPAS1 S304M
Clear Cell Renal Cell Carcinoma
EPAS1 S304M
Clear Cell Renal Cell Carcinoma
belzutifan
Sensitive: D – Preclinical
belzutifan
Sensitive
:
D
belzutifan
Sensitive: D – Preclinical
belzutifan
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login